Vutiglabridin

N/A

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameVutiglabridin
Drug Alias NameHSG-4112
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTriglyceride modulatorsInflammation mediator inhibitors
TargetsUpdating
Therapy Area/IndicationsObesityParkinson DiseaseOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaceum
China Registration ClassN/A

Develop Information

Active CompaniesGlaceum
Inactive CompaniesN/A
Active IndicationsObesityParkinson DiseaseOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A